Search

Your search keyword '"Sémiond, Dorothée"' showing total 8 results
Start Over Author "Sémiond, Dorothée" Database ScienceDirect
8 results on '"Sémiond, Dorothée"'

2. MM-071 Subcutaneous (SC) Isatuximab (Isa) Administration by an On-Body Delivery System (OBDS) in Combination With Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients: Interim Phase 1b Study Results

Author

Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, and Moreau, Philippe

Published
2022
Full Text
View/download PDF

3. Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1b Expansion Study Results

Author

Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Madan, Sumit, Semiond, Dorothee, Yu, Disa, Macé, Sandrine, Suzan, Florence, and Moreau, Philippe

Published
2022
Full Text
View/download PDF

5. P-267: Subcutaneous isatuximab administration by an on-body delivery system in combination with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: interim phase 1b study results

Author

Quach, Hang, Parmar, Gurdeep, Ocio, Enrique, Prince, H Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, and Moreau, Philippe

Published
2022
Full Text
View/download PDF

6. Corrigendum to P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) Pages S152-S153]

Author

Moreau, Philippe, Parmar, Gurdeep, Prince, Miles, Ocio, Enrique, Karenes, Chatchada, Madan, Sumit, Oriol, A, Bories, Pierre, Delforge, Michel, Galbrail, Nashat, Semiond, Dorothee, Jia, Nan, Macé, Sandrine, Suzan, Florence, and de Velde, Helgivan

Published
2022
Full Text
View/download PDF

7. P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma

Author

Moreau, Philippe, Parmar, Gurdeep, Prince, Miles, Ocio, Enrique, Karenes, Chatchada, Madan, Sumit, Oriol, A, Bories, Pierre, Delforge, Michel, Galbrail, Nashat, Semiond, Dorothee, Jia, Nan, Macé, Sandrine, Suzan, Florence, and van de Velde, Helgi

Published
2021
Full Text
View/download PDF

8. Poster: MM-071 Subcutaneous (SC) Isatuximab (Isa) Administration by an On-Body Delivery System (OBDS) in Combination With Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients: Interim Phase 1b Study Results

Author

Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, and Moreau, Philippe

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results